Pyrantel Pamoate Liquid
NDC Package 73581-110-02

11-digit billing NDC: 73581011002
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Pyrantel Pamoate liquids is shake well before useread bottle label and package insert carefully before taking this medicationtreat the entire household unless otherwise advised. This formulation utilizes a liquid delivery system. Marketed by Yyba Corp, this product is identified by NDC 73581-110 and is authorized under FDA application M024.

Identification & Billing

NDC Package Code
73581-110-02
Package Description
2 BOTTLE in 1 CARTON / 30 mL in 1 BOTTLE
Product Code
73581-110
11-Digit Billing Format
73581011002

Clinical Specifications

Proprietary Name
Pyrantel Pamoate
Non-Proprietary Name
Pyrantel Pamoate
Substance Name
Pyrantel Pamoate
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
PYRANTEL PAMOATE 144 mg/mL
Usage Information
Shake well before useread bottle label and package insert carefully before taking this medicationtreat the entire household unless otherwise advised. See Warningsdo not repeat treatment unless directed by a doctorthis product can be taken any time of day, with or without meals. It may be taken alone or with milk or fruit juice. Use of a laxative is not necessary prior to, during or after medication.If signs of pinworms persist after treatment, consult a doctor

Regulatory & Marketing

Labeler Name
Yyba Corp
Product Type
Human Otc Drug
FDA Application #
M024
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
07-13-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 73581-110-02 identifies a specific commercial package of 2 bottle in 1 carton / 30 ml in 1 bottle of Pyrantel Pamoate, a human over the counter drug labeled by Yyba Corp. This liquid is formulated for oral use and contains pyrantel pamoate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Yyba Corp on July 13, 2026. The current certification is valid through December 31, 2027.

How is this Yyba Corp product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 73581011002. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
73581-110-02
11-Digit CMS (5-4-2)
73581-0110-02

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.